Across biochemical assays, cell culture models, and preclinical animal studies, mechanistic investigations have focused on how BPC-157 interacts with nitric oxide signaling, angiogenic regulation, cytoskeletal remodeling, and epithelial or connective tissue repair processes
The purity assessment criteria for research-grade materials are generally much less rigorous, partially incomplete, and/or poorly followed, per a 2014 paper.21 Additionally, while some studies state that BPC-157 has good oral bioavailability based on its stability in human gastric juice, little if any research has investigated the differences in bioavailability between BPC-157 routes of administration.22 We could find only a single rat study that used oral BPC-157.23 So the best option would be an injectable form of BPC-157 from a reputable clinic
Topical skin irritation and allergy are different safety questions than sterile injectable compounding, immunogenicity, or systemic copper exposure
A standard 80 mg KLOW vial contains 50 mg GHK-Cu and 10 mg each of BPC-157, TB-4, and KPV
Once reconstituted, maintain at 28C and protect from excessive heat, moisture, and direct light